Patent Assignment
Reel/Frame 043041/0880
Security Interest
Recorded: 2017-07-19
Pages: 11
Assignor
SALIX PHARMACEUTICALS, LTD
Executed: 2017-07-17
Assignee
THE BANK OF NEW YORK MELLON
101 BARCLAY STREET, FLOOR 7E, NEW YORK, NEW YORK, 10286
Covered Properties
(42)
Formulations and Uses of 2-Hydroxy-5-Phenylazobenzoic Acid Derivatives
Formulations and Uses of 2-Hydroxy-5-Phenylazobenzoic Acid Derivatives
Formulations and Uses of 2-Hydroxy-5-Phenylazobenzoic Acid Derivatives
Colonic Purgative Composition with Soluble Binding Agent
Rifaximin Anti-Rectal Dysfunction Preparation
Compositions and Methods for the Treatment of Radiation Proctosigmoitis
Application:
12/309,893 →
Publication:
US 2010/0069421
Forms of Rifaximin and Uses Thereof
Methods for Treating Diarrhea-Associated Irritable Bowel Syndrome
Forms of Rifaximin and Uses Thereof
Methods of Treating Travelers Diarrhea and Hepatic Encephalopathy
Methods of Treating Traveler's Diarrhea and Hepatic Encephalopathy
Formulations and Uses of 2-Hydroxy-5-Phenylazobenzoic Acid Derivatives for the Treatment of Males
Forms of Rifaximin and Uses Thereof
Forms of Rifaximin and Uses Thereof
Forms of Rifaximin and Uses Thereof
Forms of Rifaximin and Uses Thereof
Forms of Rifaximin and Uses Thereof
Methods for Treating Infection
Application:
13/587,539 →
Publication:
US 2013/0210852
Forms of Rifaximin and Uses Thereof
Forms of Rifaximin and Uses Thereof
Methods of Treating Traveler's Diarrhea and Hepatic Encephalopathy
Methods for Treating Irritable Bowel Syndrome (Ibs) and Infections
Application:
13/667,585 →
Publication:
US 2013/0184302
Methods for Treatment and Prevention of Opioid Induced Constipation Using Oral Compositions of Methylnaltrexone
Application:
13/720,235 →
Publication:
US 2013/0317050
Methods of Treating Hepatic Encephalopathy
Methods for Treating Irritable Bowel Syndrome (Ibs)
Methods of Treating Hepatic Encephalopathy
Methods of Treating Hepatic Encephalopathy
Forms of Rifaximin and Uses Thereof
New Forms of Rifaximin and Uses Thereof
Forms of Rifaximin and Uses Thereof
Formulations of Rifaximin and Uses Thereof
Forms of Rifaximin and Uses Thereof
Forms of Rifaximin and Uses Thereof
Methods of Treating Traveler's Diarrhea and Hepatic Encephalopathy
Methods of Treating Hepatic Encephalopathy
Prevention, Treatment, and Amelioration of Radiation Induced Enteritis
Application:
14/731,692 →
Publication:
US 2016/0120886
Methods for Treating Bowel Diseases
Application:
14/799,018 →
Publication:
US 2016/0000765
Forms of Rifaximin and Uses Thereof
Forms of Rifaximin and Uses Thereof
Methods of Treating Hepatic Encephalopathy
Formulations of Rifaximin and Uses Thereof
Application:
15/281,543 →
Publication:
US 2017/0087134
Solid Dispersion Forms of Rifaximin
Application:
62/402,119 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 11, 2014
From: GUSHURST, KAREN S.; YANG, DONGLAI; VLAHOVA, PETINKA; STULTS, JEFFREY S.
To: SALIX PHARMACEUTICALS, INC.
Reel/Frame 034477/0647 →
Assignment of Assignor's Interest
Aug 11, 2016
From: GUSHURST, KAREN S.; YANG, DONGLAI; ROE, MELANIE; SCHULTHEISS, NATHAN
To: APTUIT, INC.
Reel/Frame 039653/0847 →
Assignment of Assignor's Interest
Aug 19, 2016
From: APTUIT, INC.
To: SALIX PHARMACEUTICALS, LTD.
Reel/Frame 039763/0541 →
Assignment of Assignor's Interest
Sep 25, 2017
From: PARENT, STEPHAN D.; MCQUEEN, LISA LYNN; ANDRES, PATRICIA; SCHIELDS, PAUL
To: SALIX PHARMACEUTICALS, LTD
Reel/Frame 043684/0269 →
Assignment of Assignor's Interest
Sep 25, 2017
From: APTUIT, INC.
To: SALIX PHARMACEUTICALS, LTD
Reel/Frame 043684/0383 →
Corrective Assignment to Correct the Assignee Previously Recorded at Reel: 043684 Frame: 0269. Assignor(S) Hereby Confirms the Assignment.
Oct 13, 2017
From: PARENT, STEPHAN D.; MCQUEEN, LISA LYNN; ANDRES, PATRICIA; SCHIELDS, PAUL
To: APTUIT, INC.
Reel/Frame 044280/0962 →
Security Interest
Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 045444/0634 →
Security Interest
Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 045444/0299 →
Security Interest
Mar 11, 2019
From: BAUSCH HEALTH AMERICAS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 048556/0758 →
Assignment of Assignor's Interest
Apr 22, 2019
From: SALIX PHARMACEUTICALS, LTD.
To: SALIX PHARMACEUTICALS, INC.
Reel/Frame 048953/0153 →
Assignment of Assignor's Interest
May 6, 2019
From: SALIX PHARMACEUTICALS, LTD.
To: SALIX PHARMACEUTICALS, INC.
Reel/Frame 049090/0053 →
Assignment of Assignor's Interest
May 13, 2019
From: SALIX PHARMACEUTICALS, LTD.
To: SALIX PHARMACEUTICALS, INC.
Reel/Frame 049157/0940 →
Assignment of Assignor's Interest
Jun 12, 2019
From: SALIX PHARMACEUTICALS, LTD.
To: SALIX PHARMACEUTICALS, INC.
Reel/Frame 049444/0911 →
Assignment of Assignor's Interest
Jun 25, 2019
From: SALIX PHARMACEUTICALS, LTD.
To: SALIX PHARMACEUTICALS, INC.
Reel/Frame 049579/0675 →
Assignment of Assignor's Interest
Jun 25, 2019
From: SALIX PHARMACEUTICALS, LTD.
To: SALIX PHARMACEUTICALS, INC.
Reel/Frame 049578/0095 →
Security Interest
Jun 8, 2021
From: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 056811/0814 →
Security Agreement
Feb 10, 2022
From: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION
To: THE BANK OF NEW YORK MELLON
Reel/Frame 059121/0001 →
Security Agreement (First Lien)
Oct 4, 2022
From: BAUSCH HEALTH US, LLC; BAUSCH HEALTH AMERICAS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061595/0066 →
Security Agreement (Second Lien)
Oct 5, 2022
From: BAUSCH HEALTH US, LLC; BAUSCH HEALTH AMERICAS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061606/0468 →
Release of Security Interest
Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.
Reel/Frame 070778/0199 →
U.S. Patent Security Agreement
Jun 13, 2025
From: MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.; BAUSCH HEALTH US, LLC (F/K/A VALEANT PHARMACEUTICALS NORTH AMERICA LLC); PRECISION DERMATOLOGY, INC.
To: THE BANK OF NEW YORK MELLON
Reel/Frame 071564/0463 →
U.S. Patent Security Agreement
Jun 13, 2025
From: MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.; BAUSCH HEALTH US, LLC (F/K/A VALEANT PHARMACEUTICALS NORTH AMERICA LLC); PRECISION DERMATOLOGY, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 071566/0200 →
Release of Security Interest
Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC
Reel/Frame 073637/0001 →
Release of Security Interest
Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION
Reel/Frame 073654/0242 →
Release of Security Interest
Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH HEALTH AMERICAS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.
Reel/Frame 073637/0126 →